Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy

American Journal of Ophthalmology

Volumn 130, Issue 3, 2000, Pages 367-368

  Wang, Mathew Y ^a   Arnold, Anthony C ^a   Vinters, Harry V ^b   Glasgow, Ben J ^a,b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; AUTOPSY; BLINDNESS; BONE MARROW TRANSPLANTATION; BREAST CANCER; CASE REPORT; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; MEDULLA OBLONGATA; NEUROTOXICITY; OPTIC NERVE; PRIORITY JOURNAL; RETINA ARTERY; RETINA ARTERY OCCLUSION; SPINAL CORD DISEASE;

EID: 0033800164     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00522-5     Document Type: Article

References (5)

1. Shingleton B.J., Bienfang D.C., Albert D.M., Ensminger W.D., Chandler W.F., Greenberg H.S. Ocular toxicity associated with high-dose carmustine. Arch Ophthalmol. 100:1982;1766-1772.
2. Fraunfelder F.T., Meyer S.M. Ocular toxicity of antineoplastic agents. Ophthalmology. 90:1983;1-3.
3. Caraceni A., Martini C., Spatti G., Thomas A., Onofrj M. Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy. Acta Neurol Scand. 96:1997;260-261.
4. Rubin P., Hulette C., Khawly J.A., et al. Ocular toxicity following high dose chemotherapy and autologous transplant. Bone Marrow Transplant. 18:1996;253-256.
5. Walsh T.J., Clark A.W., Parhad I.M., et al. Neurotoxic affects of cisplatin therapy. Arch Neurol. 3:1982;719-720.